AMRUTANJANPharmaceuticals
Amrutanjan Health Care Ltd — PE Ratio & Valuation Analysis
₹493.65
-1.89%
Current P/E34.82xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E39.9x12.7% below avg
⚠️
9.6% Premium to Industry
AMRUTANJAN P/E 34.82x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹17.58 | ₹669 | 38x |
| 2024 | ₹15.50 | ₹723 | 46.6x |
| 2023 | ₹13.63 | ₹599 | 44x |
| 2022 | ₹22.98 | ₹711 | 30.9x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Amrutanjan Health Care Ltd Valuation
Amrutanjan Health Care Ltd (AMRUTANJAN) currently trades at 34.82x earnings. The Pharmaceuticals sector average PE is 31.77x. AMRUTANJAN commands a premium, reflecting high growth expectations. Historically, AMRUTANJAN has traded at an average PE of 39.9x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
16.53%
Dividend Yield
0.67%
More on Amrutanjan Health Care Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.